Immunogenicity 14288
Sample ID
3784
Response
Negative
Tumor Type
Melanoma
Gene Symbol
MBNL2
Transcript ID
NM_207304
HLA INFO
B*07:01
TCR INFO
No TCR info found!
Full length protein sequence (361 aa)
MALNV
1
APVRD
6
TKWLT
11
LEVCR
16
QFQRG
21
TCSRS
26
DEECK
31
FAHPP
36
KSCQV
41
ENGRV
46
IACFD
51
SLKGR
56
CSREN
61
CKYLH
66
PPTHL
71
KTQLE
76
INGRN
81
NLIQQ
86
KTAAA
91
MLAQQ
96
MQFMF
101
PGTPL
106
HPVPT
111
FPVGP
116
AIGTN
121
TAISF
126
APYLA
131
PVTPG
136
VGLVP
141
TEILP
146
TTPVI
151
VPGSP
156
PVTVP
161
GSTAT
166
QKLLR
171
TDKLE
176
VCREF
181
QRGNC
186
ARGET
191
DCRFA
196
HPADS
201
TMIDT
206
SDNTV
211
TVCMD
216
YIKGR
221
CMREK
226
CKYFH
231
PPAHL
236
QAKIK
241
AAQHQ
246
ANQAA
251
VAAQA
256
AAAAA
261
TVMAF
266
PPGAL
271
HPLPK
276
RQALE
281
KSNGT
286
SAVFN
291
PSVLH
296
YQQAL
301
TSAQL
306
QQHAA
311
FIPTD
316
NSEII
321
SRNGM
326
ECQES
331
ALRIT
336
KHCYC
341
TYYPV
346
SSSIE
351
LPQTA
356
C
361
Mutation Information
DNA mutation:
None
Peptide Range:
107 ~ 131
Mut AA position:
119 (13 in Wild Type peptide)
Alignment
Wild Type:
"GTPLHPVPTFPVGPAIGTNTAISFA
||||||||||||.||||||||||||
Mutant:
GTPLHPVPTFPVSPAIGTNTAISFA"
Nat Med, 2016
Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patientsGene Name (from Reference) MBNL2
Checkpoint
Blockade
None
ACT
None
Vaccination
None
Curative
Effect
None
minimal_peptide
None
Antigen
Type
TMG RNA
T-cell
Source
PBMCs
APC
Type
autologous DCs
Assay
IFNg ELISPOT assay